Moderna officer plans $4.7M stock sale in 2026
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) received a Rule 144 notice that officer James M. Mock, through Fidelity Brokerage Services LLC, plans to sell up to 34,836 shares of common stock, with an indicated aggregate market value of $4,685,093.64, beginning on or about September 10, 2026.
The shares derive from multiple restricted stock vesting events between October 5, 2023 and May 28, 2025 and a planned stock option exercise of 19,836 shares for cash on September 10, 2026. Common shares outstanding are stated as 399,235,889.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold under Rule 144: 34,836 shares
Aggregate market value of shares to be sold: $4,685,093.64
Common shares outstanding: 399,235,889 shares
+3 more
6 metrics
Shares to be sold under Rule 144
34,836 shares
Planned sale of Moderna common stock for account of James M. Mock
Aggregate market value of shares to be sold
$4,685,093.64
Value reported for the 34,836 Moderna shares covered by the notice
Common shares outstanding
399,235,889 shares
Moderna common stock outstanding figure provided alongside the sale notice
Stock option exercise shares
19,836 shares
Shares to be acquired via stock option exercise for cash on September 10, 2026
Restricted stock vesting on October 5, 2023
2,952 shares
Compensation-related restricted stock vesting from issuer on October 5, 2023
Restricted stock vesting on February 27, 2025
2,966 shares
Compensation-related restricted stock vesting from issuer on February 27, 2025
Key Terms
Rule 144, Restricted Stock Vesting, Stock Option Exercise, attorney-in-fact
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 10/05/2023 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Stock Option Exercise financial
"Common | 09/10/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
attorney-in-fact regulatory
"as attorney-in-fact for James Mock"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for Moderna, Inc. (MRNA)?
It discloses that officer James M. Mock, through Fidelity Brokerage Services LLC, plans to sell up to 34,836 shares of Moderna common stock under Rule 144, with an indicated aggregate market value of $4,685,093.64, starting around September 10, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
